Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 February;61(1) > Minerva Cardioangiologica 2013 February;61(1):45-52

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  


Minerva Cardioangiologica 2013 February;61(1):45-52

language: English

The SADRA Lotus Valve System: a fully repositionable, retrievable prosthesis

Gooley R., Lockwood S., Antonis P., Meredith I. T.

MonashHEART, Monash Medical Centre, Southern Health, Melbourne, Australia


PDF  


Transcatheter aortic valve implantation (TAVI) has become the preferred treatment option for patients with severe aortic stenosis at extreme surgical risk and an acceptable alternative to surgical aortic valve replacement in patients at high risk. Despite a growing amount of evidence in support of TAVI there remain important limitations and recognized complications. The SADRA Lotus Valve System is a novel TAVI device capable of allowing full repositionability and retrievability, which may address some of the first generation limitations.

top of page

Publication History

Cite this article as

Corresponding author e-mail

ian.meredith@myheart.id.au